Krystal Biotech, Inc. revenue breakdown overview

Krystal Biotech, Inc. revenue for the last year amounted to 290.51 M USD, the most of which — 290.51 M USD — came from its highest performing source at the moment, Genetic Medicines, the year earlier bringing 50.70 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Krystal Biotech, Inc. 290.51 M USD, and the year before that — 50.70 M USD.